Search
Mar 4, 2024
Nuvalent's CEO on overcoming kinase resistance and selectivity for its precision oncology medicines
Jim Porter describes the chemistry that has led to early stage success against ALK and ROS1.
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.
bottom of page